Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

The AIDS Society of India (ASI) has called on the government to swiftly integrate HIV self-testing and pre-exposure ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product ... women – those who identify with the gender they were born with – contracted HIV while on the drug. Hasina Subedar, senior ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...

The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...